FEDERATED HERMES, INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$347,678
+17283.9%
80,481
+26115.3%
0.00%
Q3 2022$2,000
-99.8%
307
-99.8%
0.00%
-100.0%
Q2 2022$1,284,000
-4.3%
127,797
+18.0%
0.00%0.0%
Q1 2022$1,341,000
+120.6%
108,301
+307.4%
0.00%
+200.0%
Q4 2021$608,000
-62.8%
26,585
-64.0%
0.00%
-66.7%
Q3 2021$1,634,000
-21.0%
73,816
-53.7%
0.00%
-25.0%
Q2 2021$2,068,000
+23.2%
159,526
+23.5%
0.00%
+33.3%
Q1 2021$1,678,000
+6.3%
129,208
+13.3%
0.00%0.0%
Q4 2020$1,578,000
+1.1%
114,032
+7.6%
0.00%
-25.0%
Q3 2020$1,561,000106,0170.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders